Longeveron Inc.
LGVN- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001721484
No open-market purchases or sales by Longeveron Inc. insiders were filed in the last 90 days; 39 institutions reported holding it in 13F filings for Q2 2026, worth $3.35M in total; no superinvestor holds it.
13F holders, Q4 2022
Institutional positions in Longeveron Inc. as of Dec 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 17
- −1 vs. Q3 2022
- Shares held
- 449.9K
- +5.88K (+1.3%) vs. Q3 2022
- Total value
- $1.45M
- −$194.4K (−11.8%) vs. Q3 2022
- New holders
- 4
- 4 more added
- Sold out
- 5
- 4 more reduced
Compare with Q3 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting LGVN on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 39 | $3.35M |
| Q1 2026 | 31 | $2.37M |
| Q4 2025 | 30 | $520.6K |
| Q3 2025 | 29 | $783.1K |
| Q2 2025 | 25 | $868.1K |
| Q1 2025 | 21 | $790.6K |
| Q4 2024 | 24 | $844.4K |
| Q3 2024 | 19 | $512.3K |
| Q2 2024 | 21 | $534.1K |
| Q1 2024 | 12 | $161.7K |
| Q4 2023 | 22 | $3.42M |
| Q3 2023 | 19 | $1.37M |
| Q2 2023 | 21 | $2.71M |
| Q1 2023 | 16 | $1.13M |
| Q4 2022 | 17 | $1.45M |
| Q3 2022 | 18 | $1.64M |
| Q2 2022 | 14 | $2.24M |
| Q1 2022 | 14 | $9.59M |
| Q4 2021 | 19 | $5.55M |
| Q3 2021 | 13 | $1.07M |
| Q2 2021 | 12 | $2.96M |
| Q1 2021 | 10 | $561.0K |
Institutions, Q4 2022
Shares, value and share of portfolio for each institution holding Longeveron Inc.; share changes are against Q3 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Bank of America Corp | 10 | $32 | 0.00% | +10 | New |
| Wells Fargo & Company | 37 | $119 | 0.00% | +1+2.8% | Added |
| The PNC Financial Services Group, Inc. | 220 | $708 | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 991 | $3.00K | 0.00% | −427−30.1% | Reduced |
| Advisor Group Holdings, Inc. | 2,000 | $6.00K | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 3,503 | $11.3K | 0.00% | +3,503 | New |
| Morgan Stanley | 4,619 | $14.9K | 0.00% | −4,060−46.8% | Reduced |
| Byrne Asset Management LLC | 5,800 | $18.7K | 0.01% | +5,800 | New |
| Northern Trust Corp | 10,623 | $34.2K | 0.00% | 00.0% | Unchanged |
| Schonfeld Strategic Advisors LLC | 12,400 | $39.9K | 0.00% | −500−3.9% | Reduced |
| TownSquare Capital, LLC | 14,450 | $46.5K | 0.00% | 00.0% | Unchanged |
| State Street Corp | 14,800 | $47.7K | 0.00% | 00.0% | Unchanged |
| Ground Swell Capital, LLC | 23,511 | $75.7K | 0.34% | +23,511 | New |
| Susquehanna Fundamental Investments, LLC | 25,434 | $81.9K | 0.00% | −1,913−7.0% | Reduced |
| Geode Capital Management, LLC | 37,180 | $119.0K | 0.00% | +1,462+4.1% | Added |
| BlackRock Inc. | 109,945 | $354.0K | 0.00% | +216+0.2% | Added |
| Vanguard Group Inc | 184,346 | $593.6K | 0.00% | +790.0% | Added |
| XTX Topco Ltd | 0 | $0 | 0.00% | −10,683−100.0% | Sold out |
| Squarepoint Ops LLC | 0 | $0 | 0.00% | −10,356−100.0% | Sold out |
| BNP Paribas Arbitrage, SA | 0 | $0 | 0.00% | −700−100.0% | Sold out |
| FMR LLC | 0 | $0 | 0.00% | −10−100.0% | Sold out |
| Royal Bank of Canada | 0 | $0 | 0.00% | −54−100.0% | Sold out |